Target intelligence / Profile preview

MicroRNA 5692c-1 (MIR5692C1)

Target
MIR5692C1
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA, Other
01

Overview

MicroRNA 5692c-1 (MIR5692C1, hsa-mir-5692c-1) is a short (~20–24 nucleotide) regulatory RNA encoded in the human genome. Like other microRNAs, it does not encode protein but instead functions as part of the RNA-induced silencing complex (RISC), binding to target mRNAs and repressing their translation or directing their degradation. miR-5692c (which likely corresponds to MIR5692C1) has shown a role in promoting survival of endothelial cells by inhibiting PTEN and activating the AKT/ERK pathways in vitro, indicating a potential but as yet unexploited relevance to tissue regeneration or vascular biology. There are no direct links to therapeutic targeting, disease associations, or validated biomarkers for MIR5692C1 at present. The microRNA represents a basic regulatory element rather than a conventional "target" in drug discovery; its specific biological and disease-related roles remain largely uncharacterized beyond general microRNA functions. If mir-5692c and MIR5692C1 are not the same molecule, information specific to the exact string "MIR5692C1" is especially limited and general microRNA biology applies.

Other names
hsa-mir-5692c-1MIR5692C1miR-5692c-1human microRNA 5692c-1
02

Mechanism of action

As with other miRNAs: binds to 3' untranslated regions (UTRs) of target mRNAs to downregulate gene expression (via mRNA degradation or translational repression)

03

Biological functions

Post-transcriptional regulation of gene expression (miRNAs bind to complementary sequences on target mRNAs to repress translation or promote degradation)Regulation of cellular survival in endothelial cells (inferred specifically for miR-5692c, which may refer to this or a closely related microRNA)Other general microRNA functions include: modulation of apoptosis, cell proliferation, immune response, etc., but these are not directly established for MIR5692C1 itself
04

Disease associations

No direct evidence links microRNA 5692c-1 to specific diseases.General microRNA dysfunction is involved in cancer, cardiovascular disease, neurodegeneration, inflammation, and more, but there is no direct literature for MIR5692C1 in these contexts
05

Safety considerations

Not described
06

Interacting drugs

None described
07

Biomarkers

None established for MIR5692C1

Beyond the preview

Go deeper on MicroRNA 5692c-1 (MIR5692C1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 5692c-1 (MIR5692C1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call